Frequency Of Retinopathy In Hundred Cases Of Chronic Hepatitis C OnInterferon Therapy At Liaquat University Hospital Hyderabad

Authors: Shoaib Ansari, Hanif Ghani, Sameen Afzal Junejo

LIAQUAT UNIVERSITY OF MEDICAL & HEALTH SCIENCES, JAMSHORO/ HYDERABAD SINDH, PAKISTAN
Department of Medicine LIAQUAT UNIVERSITY OF MEDICAL & HEALTH SCIENCES JAMSHORORO, SINDH
PAKISTAN
LIAQUAT UNIVERSITY OF MEDICAL & HEALTH SCIENCES JAMSHORORO, SINDH PAKISTAN

Volume 16 | Issue 2

Published: November 9, 2026

Abstract

Chronic Hepatitis C is common problem world wide treated by combination
of interferon alpha and ribavirin. Retinopathy is one of the side effects of interferon therapy. The aim of this study is to determine the frequency of retinopathy in patients treated by interferon alpha and ribavirin at Liaquat University Hospital Hyderabad. STUDY DESIGN: Observational descriptive study. PLACE AND DURATION: This study was conducted in the department of Medicine Liaquat University Hospital from July 2007 to June 2009. MATERIAL AND METHODS: All chronic hepatitis C patients with positive HCV RNA by Polymerase Chain Reaction were included. Past medical history of hypertension and diabetes were taken. Full ocular examination was performed before start of treatment and at 3 months and 6 months interval. RESULTS: Total 100 patients were enrolled amongst which 23 developed retinopathy. 12/82 (14.63%) with no co-morbid illness; 7/12(58.3%) in patients with hepatitis C diabetes; 2/3(66.6%) in patients with hepatitis C and hypertension and 2/3(66.6%) in patients with hepatitis C and both diabetes and hypertension. CONCLUSION: Retinopathy may occur in patients with chronic hepatitis C receiving interferon alpha and ribavirin, commonly in patients with diabetes and hypertension.

Keywords: Retinopathy, Interferon and ribavirin, Chronic hepatitis C.

DOI: (All papers should be submitted electronically. All submitted manuscripts must be original work that is not under submission at another journal or under consideration for publication in another form, such as a monograph or chapter of a book. Authors of submitted papers are obligated not to submit their paper for publication elsewhere until an editorial decision is rendered on their submission. Further, authors of accepted papers are prohibited from publishing the results in other publications that appear before the paper is published in the Journal unless they receive approval for doing so from the Editor-In-Chief.)

Download Full Text PDF